Variables
MDR-TB and/or RMP-MR
Non MDR
Total
N (%)
N (%)
N (%)
COR(95%CI)
AOR (95% CI)
Sex
0.7 (0.44- 1.0)
0.7(0.44-1.0)
Male
57 (15.7)
306 (84.3)
363 (59.9)
Female
53 (21.8)
190 (78.2)
243 (40.1)
Age
≥ 51
9 (10.3)
78 (89.7)
87 (14.4)
1
1
41-50
13 (14)
80 (86)
93 (15.3)
1.4 (0.6-3.5)
0.7 (0.3-1.7)
31-40
25 (17.2)
120 (82.8)
145 (23.9)
1.8 (0.8-4.07)
0.5 (0.23-1.2)
21-30
47 (23.6)
152 (76.4)
199 (32.8)
2.7 (1.3-5.8)
0.4 (0.2-0.8)
Nov-20
16 (21.1)
60 (78.9)
76 (12.5)
2.3 (0.95-5.59)
0.5 (0.2-1.1)
02-Oct
0 (0)
6 (100)
6 (1)
-
-
HIV status
Negative
65 (18.9)
279 (81.1)
344 (56.8)
1
1
Positive
18 (19.4)
75 (80.6)
93 (15.3)
0.8 (0.4-1.5)
0.95 (0.5-1.7)
Un known
27 (16)
142 (84)
169 (27.9)
0.97(0.5-1.7)
1.3 (0.7-2.2)
Treatment history
New
13 (16.9)
64 (83.1)
77 (12.7)
1.1 (0.6-2.0)
0.24 (0.04-1.4)
Retreatment
97 (18.3)
432 (86.6)
529 (87.3)
TB history
New
15 (19.2)
63 (80.8)
78 (12.9)
1
1
Relapse
40 (15.9)
212 (84.1)
252 (41.6)
0.79 (0.41-1.5)
4.5 (0.8-25.5)
Failure
46 (21.7)
16 9(78.3)
215 (35.5)
1.14 (0.6-2.2)
2.9 (0.5-16)
Defaulter
7 (24.1)
22 (75.9)
29 (4.9)
0.35 (0.7-1.6)
10.6 (1-99)
Other
0 (0)
6 (100)
6 (1.00)
-
-
Unknown
2 (7.7)
24 (92.3)
26 (4.3)
1.33 (0.5-3.7)
2.5 (0.4-16.7)
Total
110 (18.2)
496 (81.8)
606 (100)
Table 3:
Logistic regression analysis for assessing association of MDR-TB and/or RMP-MR with socio demographic and clinical history among presumptive MDR-TB cases, ANRS, 2013
